News

Filter

Current filters:

Research

51 to 60 of 96672 results

Licensing deal index shows re-emergence of late-stage deals

Licensing deal index shows re-emergence of late-stage deals

28-10-2014

Licensing deals among biotech companies have recently shown a healthy surge, especially in later stages.

BiotechnologyCelgene Corp.FinancialLicensingMorrisonUK

Takeda and Lilly’s fine is reduced in Actos case

Takeda and Lilly’s fine is reduced in Actos case

28-10-2014

A US district court has reduced the damages to be paid by Japan’s largest drugmaker Takeda Pharmaceutical…

ActosDiabetesEli LillyLegalPharmaceuticalTakeda PharmaceuticalUSA

UPDATED: Sanofi chief executive Viehbacher allegedly issues letter to company board defending his position

UPDATED: Sanofi chief executive Viehbacher allegedly issues letter to company board defending his position

28-10-2014

Chris Viehbacher, chief executive of French drug major Sanofi, has urged the company’s board to clarify…

BoardroomFranceLantusPharmaceuticalSanofi

Despite restructuring costs, Amgen’s third-qtr beats expectations

Despite restructuring costs, Amgen’s third-qtr beats expectations

28-10-2014

US biotech major Amgen posted a fall in earnings for the third-quarter of 2014, due to restructuring,…

AmgenBiotechnologyFinancialThousand Oaks, CaliforniaUSA

Merck & Co third-qtr disappoints, as earnings plunge

Merck & Co third-qtr disappoints, as earnings plunge

27-10-2014

US pharma giant Merck & Co (NYSE: MRK) posted third-quarter 2014 financial results today, showing that…

FinancialKeytrudaMerck & CoOncologyPharmaceuticalRegulationUSA

Under US pressure, Indian government is getting its act together on IP matters

Under US pressure, Indian government is getting its act together on IP matters

27-10-2014

The pressure from the US government on India seems to be working. With India's intellectual property…

IndiaPatentsPharmaceuticalPoliticsPricing

Allergan posts strong results which provoke reaction from potential suitor Valeant

Allergan posts strong results which provoke reaction from potential suitor Valeant

27-10-2014

Botox maker Allergan has reported strong quarterly results amid an ongoing buyout dispute with Quebecois…

AllerganBotoxBusiness FinancePharmaceuticalUSAValeant

Pfizer to finally drop Remoxy development

27-10-2014

Shares of Durect Corp plunged 42.9% to $0.79 after it revealed that pharma giant Pfizer has decided to…

DurectLicensingNeurologicalPain TherapeuticsPfizerPharmaceuticalPosidurRemoxyUSA

Takeda licenses commercial rights to Mersana Fleximer-ADC

27-10-2014

Just seven months after the collaboration was announced, Japan’s largest drugmaker Takeda Pharmaceutical…

BiotechnologyFleximerLicensingMersana TherapeuticsMillennium PharmaceuticalsOncologyTakeda Pharmaceutical

51 to 60 of 96672 results

Parexel

Parexel

Back to top